Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Elevating Work Comp Care Through Physical Medicine Innovation
When it comes to physical therapy (PT), ensuring injured employees receive timely, effective care can be critical to recovery. We recently sat down with three of our Enlyte industry experts—Ted Smith, Dora Morris, and Kim Radcliffe—to discuss how a comprehensive physical medicine program can help deliver optimal results.
Enlyte’s 2025 Trends Report Examines ‘The Year of Generative AI’
Industry leaders discuss impact on the growing utilization of gen AI and data analytics as well as strategies addressing clinical and auto challenges across the claims landscape.
Specialty Solutions Spotlight: How Bone Growth Stimulators Accelerate Healing
Recovering from a broken bone can be a long and difficult journey, often accompanied by pain, diminished quality of life, and ongoing medical expenses. Accelerating the healing process is essential, and advancements in technology—like bone growth stimulators (BGS)—are transforming the recovery landscape.
Functional Capacity Evaluation (FCE) Frequently Asked Questions
An FCE is a comprehensive assessment used to determine an individual's physical abilities and limitations. This standardized testing process is typically conducted by a trained healthcare professional, such as a physical therapist or occupational therapist.
Clinical Oversight Reduces Claim Costs by Recommending Discharge Over Added PT
To control escalating therapy costs, a managed care organization implemented a system of regular reviews for additional physical therapy (PT) authorization requests. They sought a clinical partner with PT expertise to provide informed recommendations on whether to discharge patients or approve continued therapy.
Workers' Compensation Pharmacy Legislative and Regulatory End of Year Recap
New regulations, proposed legislation, and notable judicial developments made 2024 a significant year for workers' compensation pharmacy programs. For pharmacy benefit management (PBM) roles, staying on top of these changes is critical for compliance and operational efficiency. Here is a recap of some of the major developments in workers' compensation pharmacy we’re watching as we move into 2025.